1. Diagnostic Utility of BAP1, EZH2 and Survivin in Differentiating Pleural Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia: Immunohistochemical Study
    Sarah Adel Hakim et al, 2021, Pathology and Oncology Research CrossRef
  2. Can BAP1 expression loss in mesothelial cells be an indicator of malignancy?
    Hanife Gulnihal Ozdemir et al, 2020, Journal of Pathology and Translational Medicine CrossRef